|
|
Prepublished online as a Blood First Edition Paper on September 26, 2002; DOI 10.1182/blood-2002-05-1431.
Previous Article | Table of Contents | Next Article 
Blood, 15 February 2003, Vol. 101, No. 4, pp. 1572-1581
PHAGOCYTES
Serum amyloid A induces IL-8 secretion through a G
protein-coupled receptor, FPRL1/LXA4R
Rong He,
Hairong Sang, and
Richard D. Ye
From the Department of Pharmacology, College of
Medicine, University of Illinois, Chicago.
Host response to injury and infection is accompanied by a rapid
rise in the blood of acute-phase proteins such as serum amyloid A
(SAA). Although SAA has been used as a marker for inflammatory diseases, its role in the modulation of inflammation and immunity has
not been defined. Human neutrophils respond to SAA with secretion of
the proinflammatory cytokines interleukin 8 (IL-8) and, to a lesser
extent, tumor necrosis factor (TNF- ). The induction of IL-8
secretion by SAA involves both transcription and translation and
correlates with activation of nuclear factor B (NF- B). The proximal signaling events induced by SAA include mobilization of
intracellular Ca2+ and activation of the mitogen-activated
protein kinases ERK1/2 and p38, both required for the induced
IL-8 secretion. Pertussis toxin effectively blocks SAA-induced IL-8
secretion indicating involvement of a Gi-coupled receptor.
Overexpression of FPRL1/LXA4R in HeLa cells results in a significant
increase of the expression of NF- B and IL-8 luciferase reporters by
SAA, and an antibody against the N-terminal domain of FPRL1/LXA4R
inhibits IL-8 secretion. Lipoxin A4, which binds to FPRL1/LXA4R
specifically, decreases SAA-induced IL-8 secretion significantly.
Collectively, these results indicate that the cytokine-like
property of SAA is manifested through activation of the Gi-coupled
FPRL1/LXA4R, which has been known to mediate the anti-inflammatory
effects of lipoxin A4. The ability of FPRL1/LXA4R to mediate 2 drastically different and opposite functions suggests that it plays a
role in the modulation of inflammatory and immune responses.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Migita, T. Koga, T. Torigoshi, Y. Maeda, T. Miyashita, Y. Izumi, Y. Aiba, A. Komori, M. Nakamura, S. Motokawa, et al.
Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes
Rheumatology,
July 1, 2009;
48(7):
741 - 747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev.,
June 1, 2009;
61(2):
119 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. He, J. Zhou, C. Z. Hanson, J. Chen, N. Cheng, and R. D. Ye
Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2
Blood,
January 8, 2009;
113(2):
429 - 437.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Welch, R. P. Naikawadi, Z. Li, P. Lin, S. Ishii, T. Shimizu, C. Tiruppathi, X. Du, P. V. Subbaiah, and R. D. Ye
Opposing Effects of Platelet-Activating Factor and Lyso-Platelet-Activating Factor on Neutrophil and Platelet Activation
Mol. Pharmacol.,
January 1, 2009;
75(1):
227 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Cheng, R. He, J. Tian, P. P. Ye, and R. D. Ye
Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
J. Immunol.,
July 1, 2008;
181(1):
22 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sandri, D. Rodriguez, E. Gomes, H. P. Monteiro, M. Russo, and A. Campa
Is serum amyloid A an endogenous TLR4 agonist?
J. Leukoc. Biol.,
May 1, 2008;
83(5):
1174 - 1180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Bjorkman, J. Karlsson, A. Karlsson, M.-J. Rabiet, F. Boulay, H. Fu, J. Bylund, and C. Dahlgren
Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1
J. Leukoc. Biol.,
February 1, 2008;
83(2):
245 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Christenson, L. Bjorkman, C. Tangemo, and J. Bylund
Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1
J. Leukoc. Biol.,
January 1, 2008;
83(1):
139 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lin, W. Wei, J. Zhang, S. Liu, Y. Liu, and D. Zheng
Formyl peptide receptor-like 1 mediated endogenous TRAIL gene expression with tumoricidal activity
Mol. Cancer Ther.,
October 1, 2007;
6(10):
2618 - 2625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. El Kebir, L. Jozsef, T. Khreiss, W. Pan, N. A. Petasis, C. N. Serhan, and J. G. Filep
Aspirin-Triggered Lipoxins Override the Apoptosis-Delaying Action of Serum Amyloid A in Human Neutrophils: A Novel Mechanism for Resolution of Inflammation
J. Immunol.,
July 1, 2007;
179(1):
616 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, S. Zhou, and C.-K. Heng
Impact of Serum Amyloid A on Tissue Factor and Tissue Factor Pathway Inhibitor Expression and Activity in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
July 1, 2007;
27(7):
1645 - 1650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Miao, B. A. Premack, Z. Wei, Y. Wang, C. Gerard, H. Showell, M. Howard, T. J. Schall, and R. Berahovich
Proinflammatory Proteases Liberate a Discrete High-Affinity Functional FPRL1 (CCR12) Ligand from CCL23
J. Immunol.,
June 1, 2007;
178(11):
7395 - 7404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. D'Acquisto, A. Merghani, E. Lecona, G. Rosignoli, K. Raza, C. D. Buckley, R. J. Flower, and M. Perretti
Annexin-1 modulates T-cell activation and differentiation
Blood,
February 1, 2007;
109(3):
1095 - 1102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-S. Lee, S.-A. Yoo, C.-S. Cho, P.-G. Suh, W.-U. Kim, and S. H. Ryu
Serum Amyloid A Binding to Formyl Peptide Receptor-Like 1 Induces Synovial Hyperplasia and Angiogenesis
J. Immunol.,
October 15, 2006;
177(8):
5585 - 5594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. He, L. W. Shepard, J. Chen, Z. K. Pan, and R. D. Ye
Serum Amyloid A Is an Endogenous Ligand That Differentially Induces IL-12 and IL-23
J. Immunol.,
September 15, 2006;
177(6):
4072 - 4079.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Shah, R. Hari-Dass, and J. G. Raynes
Serum amyloid A is an innate immune opsonin for Gram-negative bacteria
Blood,
September 1, 2006;
108(5):
1751 - 1757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Y. Lee, M.-K. Kim, K. S. Park, E. H. Shin, S. H. Jo, S. D. Kim, E. J. Jo, Y.-N. Lee, C. Lee, S.-H. Baek, et al.
Serum Amyloid A Induces Contrary Immune Responses via Formyl Peptide Receptor-Like 1 in Human Monocytes
Mol. Pharmacol.,
July 1, 2006;
70(1):
241 - 248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Pellme, M. Morgelin, H. Tapper, U.-H. Mellqvist, C. Dahlgren, and A. Karlsson
Localization of human neutrophil interleukin-8 (CXCL-8) to organelle(s) distinct from the classical granules and secretory vesicles
J. Leukoc. Biol.,
March 1, 2006;
79(3):
564 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. G. Hayhoe, A. M. Kamal, E. Solito, R. J. Flower, D. Cooper, and M. Perretti
Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement
Blood,
March 1, 2006;
107(5):
2123 - 2130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hagihara, T. Nishikawa, Y. Sugamata, J. Song, T. Isobe, T. Taga, and K. Yoshizaki
Essential role of STAT3 in cytokine-driven NF-{kappa}B-mediated serum amyloid A gene expression
Genes Cells,
November 1, 2005;
10(11):
1051 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Edwards, C. Bologa, S. M. Young, K. V. Balakin, E. R. Prossnitz, N. P. Savchuck, L. A. Sklar, and T. I. Oprea
Integration of Virtual Screening with High-Throughput Flow Cytometry to Identify Novel Small Molecule Formylpeptide Receptor Antagonists
Mol. Pharmacol.,
November 1, 2005;
68(5):
1301 - 1310.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Simoes and I. M. Fierro
Involvement of the Rho-Kinase/Myosin Light Chain Kinase Pathway on Human Monocyte Chemotaxis Induced by ATL-1, an Aspirin-Triggered Lipoxin A4 Synthetic Analog
J. Immunol.,
August 1, 2005;
175(3):
1843 - 1850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hari-Dass, C. Shah, D. J. Meyer, and J. G. Raynes
Serum Amyloid A Protein Binds to Outer Membrane Protein A of Gram-negative Bacteria
J. Biol. Chem.,
May 13, 2005;
280(19):
18562 - 18567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. N. Baranova, T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen, M. L. Kimelman, A. T. Remaley, G. Csako, F. Thomas, T. L. Eggerman, et al.
Serum Amyloid A Binding to CLA-1 (CD36 and LIMPII Analogous-1) Mediates Serum Amyloid A Protein-induced Activation of ERK1/2 and p38 Mitogen-activated Protein Kinases
J. Biol. Chem.,
March 4, 2005;
280(9):
8031 - 8040.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lin, E. J. Welch, X.-P. Gao, A. B. Malik, and R. D. Ye
Lysophosphatidylcholine Modulates Neutrophil Oxidant Production through Elevation of Cyclic AMP
J. Immunol.,
March 1, 2005;
174(5):
2981 - 2989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. He, M. Nanamori, H. Sang, H. Yin, M. C. Dinauer, and R. D. Ye
Reconstitution of Chemotactic Peptide-Induced Nicotinamide Adenine Dinucleotide Phosphate (Reduced) Oxidase Activation in Transgenic COS-phox Cells
J. Immunol.,
December 15, 2004;
173(12):
7462 - 7470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Jo, H.-Y. Lee, Y.-N. Lee, J. I. Kim, H.-K. Kang, D.-W. Park, S.-H. Baek, J.-Y. Kwak, and Y.-S. Bae
Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-{kappa}B in Human Neutrophils
J. Immunol.,
November 15, 2004;
173(10):
6433 - 6439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Schleimer
Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium
Proceedings of the ATS,
November 1, 2004;
1(3):
222 - 230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nanamori, X. Cheng, J. Mei, H. Sang, Y. Xuan, C. Zhou, M.-W. Wang, and R. D. Ye
A Novel Nonpeptide Ligand for Formyl Peptide Receptor-Like 1
Mol. Pharmacol.,
November 1, 2004;
66(5):
1213 - 1222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Sha, A. Q. Truong-Tran, J. R. Plitt, L. A. Beck, and R. P. Schleimer
Activation of Airway Epithelial Cells by Toll-Like Receptor Agonists
Am. J. Respir. Cell Mol. Biol.,
September 1, 2004;
31(3):
358 - 364.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Li, C. A. Rivera, A. R. Burns, and C. W. Smith
Hindlimb unloading depresses corneal epithelial wound healing in mice
J Appl Physiol,
August 1, 2004;
97(2):
641 - 647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Bae, H. Y. Lee, E. J. Jo, J. I. Kim, H.-K. Kang, R. D. Ye, J.-Y. Kwak, and S. H. Ryu
Identification of Peptides That Antagonize Formyl Peptide Receptor-Like 1-Mediated Signaling
J. Immunol.,
July 1, 2004;
173(1):
607 - 614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. McMahon and C. Godson
Lipoxins: endogenous regulators of inflammation
Am J Physiol Renal Physiol,
February 1, 2004;
286(2):
F189 - F201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Partida-Sanchez, P. Iribarren, M. E. Moreno-Garcia, J.-L. Gao, P. M. Murphy, N. Oppenheimer, J. M. Wang, and F. E. Lund
Chemotaxis and Calcium Responses of Phagocytes to Formyl Peptide Receptor Ligands Is Differentially Regulated by Cyclic ADP Ribose
J. Immunol.,
February 1, 2004;
172(3):
1896 - 1906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-S. Bae, H. J. Yi, H.-Y. Lee, E. J. Jo, J. I. Kim, T. G. Lee, R. D. Ye, J.-Y. Kwak, and S. H. Ryu
Differential Activation of Formyl Peptide Receptor-Like 1 by Peptide Ligands
J. Immunol.,
December 15, 2003;
171(12):
6807 - 6813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Itagaki and C. J. Hauser
Sphingosine 1-Phosphate, a Diffusible Calcium Influx Factor Mediating Store-operated Calcium Entry
J. Biol. Chem.,
July 18, 2003;
278(30):
27540 - 27547.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|